[144] Willdan Group, Inc. SEC Filing
Willdan Group, Inc. (WLDN) submitted a Form 144 notice for the proposed resale of 850 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $101,541.00. The filing shows the shares to be sold are part of restricted stock grants acquired on 12/06/2022 (661 shares) and 12/06/2023 (189 shares). The filing reports 14,665,087 shares outstanding and lists an approximate sale date of 08/14/2025 on NASDAQ. No securities were reported sold by the person in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
- Form 144 has been filed, demonstrating regulatory compliance with Rule 144 resale requirements
- Securities originate from restricted stock grants with clear acquisition dates (12/06/2022 and 12/06/2023)
- An insider proposes to sell 850 shares (aggregate value $101,541), which may be viewed negatively by some investors despite being a small amount
Insights
TL;DR: Routine resale notice for a modest block of restricted shares; unlikely to move valuations materially.
The Form 144 documents an intended public resale of 850 shares valued at $101,541 via Morgan Stanley Smith Barney. The shares derive from restricted stock grants issued in 2022 and 2023, indicating these are previously restricted insider holdings becoming eligible for resale under Rule 144. With 14.66 million shares outstanding, the quantity represents a very small fraction of outstanding equity. The filing contains no disclosures of recent sales by the holder and affirms no undisclosed material adverse information. From a market-impact perspective, this is a routine compliance filing rather than a material event.
TL;DR: Filing shows standard compliance with disclosure obligations for planned insider resale of restricted grants.
The notice reflects governance and regulatory compliance: the filer identifies the broker, the class, acquisition dates, and the nature of acquisition as restricted stock. The seller’s signed representation that no material nonpublic information is known is standard and required. There are no indications of accelerated insider selling or coordination with other sales; the form also reports no sales in the prior three months. This aligns with expected procedures when restricted awards become eligible for public resale.